People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Other, Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ZICO Rising, Inc. | — | Other | Series A | $29.4M | $6.8M | 2022 |
| INVO Bioscience, Inc. | — | Biotech | Seed | $7.8M | $29.2M | 2023 |
| SOS Hydration Inc. | — | Other | Series A | $6.1M | $37.3M | 2022 |
Rebecca Messina at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rebecca Messina on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Rampolla | 1 | 7 |
| Michael Campbell | 1 | 6 |
| Matthew Szot | 1 | 4 |
| MICHAEL J. CAMPBELL | 1 | 4 |
| Trent Davis | 1 | 4 |
| Steven Shum | 1 | 3 |
| Christopher Gallant | 1 | 3 |
| Andrea Goren | 1 | 2 |
| Alexandre Ruberti | 1 | 2 |
| Mark Waller | 1 | 2 |
| Charles Muth | 1 | 2 |
| Kevin Doody | 1 | 1 |
| Kathleen T. Karloff | 1 | 1 |
| Robert Ludecke | 1 | 1 |
| James Mayo | 1 | 1 |
| Simon Winter | 1 | 1 |
| Blanca Lizaola-Mayo | 1 | 1 |
| Tom Mayo | 1 | 1 |
| Rebecca 80501 | 1 | 1 |
| Thomas Mayo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.